SpeechPathology.com Phone: 800-242-5183


Epic Special Education Staffing - Completion Bonus - April 2026

What Are the Modifiable Risk Factors for Dementia?

Kim McCullough, PhD, CCC-SLP

July 15, 2026

Question

What are the modifiable risk factors for dementia?

Answer

I want to direct your attention to the Livingston and colleagues 2024 article, which discusses the fact that nearly 45% of dementias could theoretically be prevented by eliminating 14 modifiable risk factors. These risk factors include controlling diabetes and LDL cholesterol, treating blood pressure, preventing head injury, reducing air pollution, addressing and treating depression, stopping smoking, maintaining a healthy weight, avoiding excessive alcohol, addressing vision loss, addressing hearing loss, promoting social connections and avoiding isolation, encouraging cognitively stimulating activities, and encouraging exercise. These 14 factors work through several mechanisms: reducing neuropathology, decreasing vascular damage, reducing inflammation and stress, and improving and maintaining cognitive reserve.

I want to make clear why these belong in a group intervention program. By conducting group sessions, we are simultaneously addressing several of these factors. We are promoting social connections and helping individuals avoid isolation. We are encouraging cognitively stimulating activities. We are providing the knowledge and motivation to address others. These wellness education topics fit naturally into the group format and are substantive. When we talk about this research with our participants, we are not just delivering information. We are giving people a sense of agency over their own futures.

I also want to reinforce a message I carry through all of our programming: you need to empower and educate older adults with subjective cognitive decline and mild cognitive impairment that they indeed have some control over what happens next. That empowerment is itself a clinical tool. Evidence is building that almost half of dementias could be prevented by addressing these 14 risk factors, and communicating that to our participants with clarity and conviction changes how they engage with the program and with their own health behaviors.

This Ask the Expert is an edited excerpt from the course, Mild Cognitive Impairment (MCI): Assessment and Treatment, presented by Kim McCullough, PhD, CCC-SLP.

Continued and its subsidiaries provide professional education authored by qualified Subject Matter Experts for continuing education purposes. These materials are intended for educational purposes and do not constitute medical advice or a substitute for individual clinical judgment. Continued is not a clinical healthcare provider; the licensed professional is solely responsible for ensuring that the application of any techniques or information presented is within their legal scope of practice and jurisdictional requirements.


kim mccullough

Kim McCullough, PhD, CCC-SLP

Kim McCullough, PhD, CCC-SLP, is a Professor and the Speech-Language Pathology Graduate Program Director at Appalachian State University. Kim is a certified speech-language pathologist with clinical expertise in providing services to individuals with neurogenic communication disorders. Kim’s clinical activities and research focus on aging, mild cognitive impairment, dementia, and interventions for sustaining brain function. Kim has worked with community partners for over two decades to provide multi-component cognitive wellness programs for older adults with concerns about changes in memory and thinking as well as with those who have a diagnosis of mild cognitive impairment or dementia. 

 


Related Courses

20Q: Mild Cognitive Impairment - The SLP’s Role in Service Delivery
Presented by Kim McCullough, PhD, CCC-SLP, Anne Hunter Cox
Text

Presenters

Kim McCullough, PhD, CCC-SLPAnne Hunter Cox
Course: #10527Level: Intermediate1 Hour
  'Very well organized flow of information'   Read Reviews
Increasingly, SLPs are serving individuals with Mild Cognitive Impairment (MCI). MCI, cognitive reserve, and modifiable risk factors that can reduce the risk of dementia are defined and described in this course. An overview of cognitive/communicative deficits associated with MCI, as well as assessment and management considerations, is also provided.

Mild Cognitive Impairment (MCI): Assessment and Treatment
Presented by Kim McCullough, PhD, CCC-SLP
Video

Presenter

Kim McCullough, PhD, CCC-SLP
Course: #11362Level: Introductory1 Hour
  'Wealth of information'   Read Reviews
With the growing prevalence of Mild Cognitive Impairment (MCI), speech-language pathologists play an important role in early identification and intervention. This course explores the characteristics of MCI and examines current best-practice guidelines for assessment and treatment.

Textbook: Cognitive Communication Disorders of MCI and Dementia - Definition, Assessment, and Clinical Management
Presented by Kim McCullough, PhD, CCC-SLP, Kathryn A. Bayles, PhD, ASHA Fellow, Cheryl Tomoeda, MS, CCC-SLP
Text

Presenters

Kim McCullough, PhD, CCC-SLPKathryn A. Bayles, PhD, ASHA FellowCheryl Tomoeda, MS, CCC-SLP
Course: #10911Level: Intermediate15.5 Hours
  'Newly learned information'   Read Reviews
Based on the textbook Cognitive Communication Disorders of MCI and Dementia: Definition, Assessment, and Clinical Management, this course provides the knowledge to diagnose and treat individuals with cognitive-communicative disorders associated with aging, mild cognitive impairment (MCI), and dementia-producing diseases, our fastest growing clinical population.

Treatment of Mild Cognitive Impairment
Presented by Kim McCullough, PhD, CCC-SLP
Video

Presenter

Kim McCullough, PhD, CCC-SLP
Course: #8633Level: Intermediate1 Hour
  'Excellent presentation, very thoughtful presenter, very encouraging information, the example activities were very useful'   Read Reviews
This course will focus on the treatment of MCI using current best practices. Intervention structure and content, as well as examples of strategies and activities for clinical implementation will be reviewed.

Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Video

Presenter

Debra M. Suiter, PhD, CCC-SLP, BCS-S
Course: #9732Level: Intermediate1 Hour
  'excellent presenter'   Read Reviews
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.